UVEAL MELANOMA, METASTATIC
Clinical trials for UVEAL MELANOMA, METASTATIC explained in plain language.
Never miss a new study
Get alerted when new UVEAL MELANOMA, METASTATIC trials appear
Sign up with your email to follow new studies for UVEAL MELANOMA, METASTATIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill tested for rare, spreading eye cancer
Disease control Recruiting nowThis study is testing a new oral drug called NBM-BMX for people with metastatic uveal melanoma, a rare type of eye cancer that has spread. The main goals are to find a safe and effective dose, learn about side effects, and see if the drug can shrink or slow the growth of tumors. …
Matched conditions: UVEAL MELANOMA, METASTATIC
Phase: PHASE1, PHASE2 • Sponsor: Novelwise Pharmaceutical Corporation • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New Immune-Boosting drug enters first human trials for Tough-to-Treat cancers
Disease control Recruiting nowThis is a first-in-human study to find a safe dose of a new drug called MBS8 for people with advanced solid tumors that have stopped responding to standard treatments. The trial will test the drug alone and in combination with an existing immunotherapy in specific groups of melan…
Matched conditions: UVEAL MELANOMA, METASTATIC
Phase: PHASE1 • Sponsor: MonTa Biosciences ApS • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Radioactive drug trial offers hope for advanced melanoma patients
Disease control Recruiting nowThis early-stage trial is testing a new radioactive drug for adults with advanced melanoma that has spread or cannot be removed by surgery. The main goals are to find the safest dose and see if the drug can shrink tumors. Participants receive the drug once every six weeks for up …
Matched conditions: UVEAL MELANOMA, METASTATIC
Phase: PHASE1 • Sponsor: Alpha-9 Oncology USA Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New hope for rare eye cancer: scientists test Dual-Attack treatment
Disease control Recruiting nowThis early-stage trial is testing the safety of combining two drugs, tebentafusp and roginolisib, for people with advanced uveal melanoma, a rare and aggressive eye cancer. The study aims to find the safest and most effective dose of this combination for future research. It is fo…
Matched conditions: UVEAL MELANOMA, METASTATIC
Phase: PHASE1 • Sponsor: St Vincent's Hospital, Sydney • Aim: Disease control
Last updated Mar 16, 2026 15:25 UTC